Evidence map›Paper›PMID 41145505›Full record

ArticleNature communications2025

The diagnostic potential of proteomics and machine learning in Lyme neuroborreliosis.

Annelaura Bach Nielsen, Lasse Fjordside, Lylia Drici, Maud Eline Ottenheijm, Christine Rasmussen, Anna J Henningsson, Lene Holm Harritshøj, Matthias Mann, Helene Mens, Anne-Mette Lebech and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Serum Borrelia IgG as a rule-out test in suspected lyme neuroborreliosis: a large retrospective cohort study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Annelaura Bach Nielsen *Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.ORCID http://orcid.org/0009-0005-2855-208X
Lasse Fjordside *Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Lylia DriciNNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-6633-1721
Maud Eline OttenheijmDepartment of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
Christine RasmussenDepartment of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
Anna J HenningssonDepartment of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.ORCID http://orcid.org/0000-0002-9315-8901
Lene Holm HarritshøjDepartment of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
Matthias MannNNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-1292-4799
Helene MensDepartment of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Anne-Mette LebechDepartment of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-0943-3289
Nicolai J Wewer AlbrechtsenDepartment of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark. nicolai.albrechtsen@regionh.dk.ORCID http://orcid.org/0000-0003-4230-5753

Funding

Det Frie Forskningsråd (Danish Council for Independent Research) 1052-00003BLundbeckfonden (Lundbeck Foundation) R366-2021-127Novo Nordisk Fonden (Novo Nordisk Foundation) NNF14CC0001Novo Nordisk Fonden (Novo Nordisk Foundation) NNF19OC0055001Novo Nordisk Fonden (Novo Nordisk Foundation) NNF23OC0084970Novo Nordisk Fonden (Novo Nordisk Foundation) NNF24OC0088402
6 · The paper itself

Abstract

Lyme neuroborreliosis (LNB), a nervous system infection caused by tick-borne spirochetes of the Borrelia burgdorferi sensu lato complex, is among the most frequent bacterial infections of the nervous system in Europe. Early diagnosis and continuous monitoring remain challenging due to limited sensitivity and specificity of current methods and requires invasive lumbar punctures, underscoring the need for improved, less invasive diagnostic tools. Here, we apply mass spectrometry-based proteomics to analyse 308 cerebrospinal fluid (CSF) samples and 207 plasma samples from patients with LNB, viral meningitis, controls and other manifestations of Lyme borreliosis. Diagnostic panels of regulated proteins are identified and evaluated through machine learning-assisted proteome analyses. In CSF, the classifier distinguishes LNB from viral meningitis and controls with AUCs of 0.92 and 0.90, respectively. In plasma, LNB is distinguished from controls with an AUC of 0.80. Our findings suggest a potential diagnostic role for machine learning-assisted proteomics in adults with LNB.

Indexed as

Lyme NeuroborreliosisMachine LearningProteomicsAdultAgedBiomarkersFemaleHumansMaleMass SpectrometryMeningitis, ViralMiddle AgedProteomeYoung AdultBiomarkersProteome

Identifiers

PMID41145505
PMCPMC12559183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.